logo

For the Inventor, By the Inventor

Toronto, Canada

Centre for Addiction and Mental Health


USPTO Granted Patents = 47



Forward Citations = 34

Loading Chart...
Loading Chart...

50 inventors (with patents filed for the assignee):

goldMedal John B Vincent (14 out of 15 patents)

silverMedal Fang Liu (10 out of 11 patents)

bronzeMedal James Lowery Kennedy (10 out of 10 patents)

4.  Berge Minassian (6 out of 17 patents)

5.  Jeffrey Hugh Meyer (6 out of 6 patents)

6.  Clement C Zai (5 out of 5 patents)

7.  Muhammad Ayub (4 out of 4 patents)

8.  Christian Windpassinger (3 out of 3 patents)

9.  Stefan Quasthoff (3 out of 3 patents)

10.  James M Cook (2 out of 51 patents)

11.  Guanguan Li (2 out of 6 patents)

12.  Michael Ming-Jin Poe (2 out of 6 patents)

13.  Miroslav M Savic (2 out of 3 patents)

14.  Etienne Sibille (2 out of 3 patents)

15.  Daniel J Mueller (2 out of 2 patents)


Core Competencies:
AMPA Receptor Signaling
Psychosis Symptoms Detection
Neurodegenerative Disorders
Genetic Markers
Antipsychotic Medication-Induced Weight Gain
Biomarkers for Autism
Dopamine Receptor Modulation
Mood Disorders Treatment
Multiple Sclerosis Treatment
Joubert Syndrome Diagnostics
Dopamine Neurotransmission
Antidepressant Induced Mania

47 patents:

1. 12398139 - Modulators of AMPA receptor signaling (2025-08-26),
2. 12230384 - Medical tool aiding diagnosed psychosis patients in detecting auditory psychosis symptoms associated with psychosis (2025-02-18),
3. 11753412 - Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatric disorders with Alpha5-containing GABAreceptor agonists (2023-09-12),
4. 11684647 - Methods, compositions, and kits addressing depressed mood (2023-06-27),
5. 11104952 - Genetic markers for suicide risk and related methods (2021-08-31),
6. 10906909 - Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatric disorders with ALPHA5-containing GABAA receptor agonists (2021-02-02),
7. 10828343 - Methods, compositions, and kits addressing depressed mood (2020-11-10),
8. 10745736 - Markers for mood disorders (2020-08-18),
9. 10662475 - Compositions and methods for the treatment and prevention of antipsychotic medication-induced weight gain (2020-05-26),
10. 10577658 - MECP2E1 gene (2020-03-03),
11. 10577657 - MECP2E1 gene (2020-03-03),
12. 10526653 - Biomarkers for autism spectrum disorders (2020-01-07),
13. 10478467 - Methods and compositions addressing depressed mood (2019-11-19),
14. 10435748 - Genetic markers associated with suicide risk and methods of use thereof (2019-10-08),
15. 10302625 - Peripheral measure of central brain inflammation, markers therefor and uses thereof (2019-05-28),
The Centre for Addiction and Mental Health (CAMH) is Canada's largest mental health teaching hospital and one of the world's leading research institutions in the field of addiction and mental health. It provides a wide range of clinical care services, research, education, and advocacy initiatives to address mental health and addiction problems. CAMH is committed to reducing the stigma surrounding mental illnesses and improving the overall mental health and well-being of individuals and communities.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

...
47 Patents

#28 in Toronto

#280 in Canada

#14,414 in the World

...
Toronto, Canada

Centre for Addiction and Mental Health

Forward Citations = 34

50 inventors:

goldMedal John B Vincent (14 out of 15 patents)

silverMedal Fang Liu (10 out of 11 patents)

bronzeMedal James Lowery Kennedy (10 out of 10 patents)

4.  Berge Minassian (6 out of 17 patents)

5.  Jeffrey Hugh Meyer (6 out of 6 patents)

Please report any incorrect information to support@idiyas.com
Loading…